441 filings
Page 3 of 23
6-K
CLLS
Cellectis
31 May 23
Current report (foreign)
4:58pm
6-K
CLLS
Cellectis
22 May 23
Current report (foreign)
5:13pm
6-K
CLLS
Cellectis
17 May 23
Cellectis Presents Clinical Data on AMELI-01 and Preclinical Data on Multiplex Engineering for Superior Generation of CAR T-cells at ASGCT 2023
4:40pm
6-K
CLLS
Cellectis
12 May 23
Current report (foreign)
6:00am
6-K
CLLS
Cellectis
11 May 23
Cellectis Announces Poster Presentation on BALLI-01 at the European Hematology Association (EHA) 2023
4:35pm
6-K
CLLS
Cellectis
4 May 23
Current report (foreign)
4:26pm
6-K
CLLS
Cellectis
2 May 23
Current report (foreign)
4:40pm
6-K
CLLS
Cellectis
27 Apr 23
Current report (foreign)
4:36pm
6-K
CLLS
Cellectis
24 Apr 23
Cellectis Implements CLLS52 for the First Time in the Clinic with Sanofi’s Alemtuzumab
4:38pm
6-K
CLLS
Cellectis
17 Apr 23
Current report (foreign)
6:05am
6-K
CLLS
Cellectis
11 Apr 23
Cellectis Announces Dosing of the First Patient in Europe with its In-house Manufactured Product Candidate UCART22
4:35pm
6-K
CLLS
Cellectis
4 Apr 23
Current report (foreign)
4:30pm
6-K
CLLS
Cellectis
14 Mar 23
Current report (foreign)
5:05pm
20-F
2022 FY
CLLS
Cellectis
Annual report (foreign)
14 Mar 23
4:01pm
6-K
CLLS
Cellectis
8 Mar 23
Cellectis Provides Business Update and Reports Fourth Quarter and Full Year 2022 Financial Results
4:52pm
6-K
CLLS
Cellectis
6 Mar 23
Calyxt, Inc. Reports its Fourth Quarter 2022 Financial Results and Provides Corporate Update
4:40pm
6-K
CLLS
Cellectis
1 Mar 23
Current report (foreign)
4:41pm
SC 13G/A
CLLS
Cellectis
14 Feb 23
Cellectis / Long Focus Capital Management ownership change
4:02pm
SC 13D/A
CLLS
Cellectis
14 Feb 23
Cellectis / Bpifrance Participations ownership change
12:34pm
6-K
CLLS
Cellectis
8 Feb 23
Current report (foreign)
8:10am